Orange Book product · Generic (ANDA)
ETODOLAC
ETODOLAC
At a glance
Nov 30, 2018
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 30, 2018
7 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
ETODOLAC
Strength
400MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 209888
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETODOLAC
- 1996LODINE XLBrand (NDA)
NDA 020584 · WYETH PHARMS INC
- 1991LODINEBrand (NDA)
NDA 018922 · WYETH PHARMS INC
- 2024ETODOLACGeneric (ANDA)
ANDA 205448 · IPCA LABS LTD
- 2024ETODOLACGeneric (ANDA)
ANDA 204729 · IPCA LABS LTD
- 2020ETODOLACGeneric (ANDA)
ANDA 210704 · PHARMACO
- 2020ETODOLACGeneric (ANDA)
ANDA 212263 · UNICHEM
- 2018ETODOLACGeneric (ANDA)
ANDA 208834 · AMNEAL PHARMS CO
- 2014ETODOLACGeneric (ANDA)
ANDA 091134 · ZYDUS PHARMS
- 2003ETODOLACGeneric (ANDA)
ANDA 076174 · TARO
- 2002ETODOLACGeneric (ANDA)
ANDA 076004 · APOTEX
- 2002ETODOLACGeneric (ANDA)
ANDA 075943 · ANI PHARMS
- 2001ETODOLACGeneric (ANDA)
ANDA 075829 · WATSON LABS FLORIDA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
